trapidil has been researched along with DDD MPGNII in 3 studies
Trapidil: A coronary vasodilator agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gesualdo, L | 2 |
| Di Paolo, S | 2 |
| Ranieri, E | 2 |
| Schena, FP | 2 |
| Pannarale, G | 1 |
| Futamura, A | 1 |
| Izumino, K | 1 |
| Nakagawa, Y | 1 |
| Takata, M | 1 |
| Inoue, H | 1 |
| Iida, H | 1 |
1 review available for trapidil and DDD MPGNII
| Article | Year |
|---|---|
Platelet-derived growth factor and proliferative glomerulonephritis.
Topics: Animals; Gene Expression; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Humans; P | 1993 |
2 other studies available for trapidil and DDD MPGNII
| Article | Year |
|---|---|
Trapidil inhibits human mesangial cell proliferation: effect on PDGF beta-receptor binding and expression.
Topics: 3T3 Cells; Animals; Cell Division; Cell Line; Gene Expression; Glomerular Mesangium; Glomerulonephri | 1994 |
Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats.
Topics: Animals; Cell Division; Cells, Cultured; Female; Glomerular Mesangium; Glomerulonephritis, Membranop | 1999 |